Literature DB >> 25747809

From "retailers" to health care providers: Transforming the role of community pharmacists in chronic disease management.

Elias Mossialos1, Emilie Courtin2, Huseyin Naci2, Shalom Benrimoj3, Marcel Bouvy4, Karen Farris5, Peter Noyce6, Ingrid Sketris7.   

Abstract

Community pharmacists are the third largest healthcare professional group in the world after physicians and nurses. Despite their considerable training, community pharmacists are the only health professionals who are not primarily rewarded for delivering health care and hence are under-utilized as public health professionals. An emerging consensus among academics, professional organizations, and policymakers is that community pharmacists, who work outside of hospital settings, should adopt an expanded role in order to contribute to the safe, effective, and efficient use of drugs-particularly when caring for people with multiple chronic conditions. Community pharmacists could help to improve health by reducing drug-related adverse events and promoting better medication adherence, which in turn may help in reducing unnecessary provider visits, hospitalizations, and readmissions while strengthening integrated primary care delivery across the health system. This paper reviews recent strategies to expand the role of community pharmacists in Australia, Canada, England, the Netherlands, Scotland, and the United States. The developments achieved or under way in these countries carry lessons for policymakers world-wide, where progress thus far in expanding the role of community pharmacists has been more limited. Future policies should focus on effectively integrating community pharmacists into primary care; developing a shared vision for different levels of pharmacist services; and devising new incentive mechanisms for improving quality and outcomes.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Chronic diseases; Community pharmacists; Cross-national comparison; Incentives

Mesh:

Year:  2015        PMID: 25747809     DOI: 10.1016/j.healthpol.2015.02.007

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  96 in total

1.  Applying participatory design to a pharmacy system intervention.

Authors:  Apoorva Reddy; Corey A Lester; Jamie A Stone; Richard J Holden; Cynthia H Phelan; Michelle A Chui
Journal:  Res Social Adm Pharm       Date:  2018-11-27

2.  General practitioners' perceptions of the current status and pharmacists' contribution to primary care in Iceland.

Authors:  Anna Bryndis Blondal; Jon Steinar Jonsson; Sofia Kälvemark Sporrong; Anna Birna Almarsdottir
Journal:  Int J Clin Pharm       Date:  2017-06-14

3.  Impact of pharmaceutical care on mental well-being and perceived health among community-dwelling individuals with type 2 diabetes.

Authors:  Zheng Kang Lum; Melanie Yee Lee Siaw; Michelle Jia Xin Lee; Zexuan Koh; Parry Quan Zhang; Soo Kiang Eng; Swee Chin Tan; Joyce Yu-Chia Lee
Journal:  Qual Life Res       Date:  2019-07-29       Impact factor: 4.147

4.  Physicians' and Pharmacists' Clinical Considerations for Elderly Patients with Type 2 Diabetes Mellitus: The IMPLICA2 Study.

Authors:  Josep Franch-Nadal; Fermín García-Gollarte; Alfonso Pérez Del Molino; María L Orera-Peña; Marta Rodríguez de Miguel; Malena Melogno-Klinkas; Héctor D de Paz; Susana Aceituno; Patricia Rodríguez-Fortúnez
Journal:  Clin Drug Investig       Date:  2019-01       Impact factor: 2.859

5.  Work Profile Factors Identified From the Career Pathway Evaluation Program, 2018 Pharmacist Profile Survey.

Authors:  Jon C Schommer; Elliott M Sogol; Lawrence M Brown
Journal:  Am J Pharm Educ       Date:  2019-12       Impact factor: 2.047

6.  Development of a Postgraduate Community Pharmacist Specialization Program Using CanMEDS Competencies, and Entrustable Professional Activities.

Authors:  Marnix P D Westein; Harry de Vries; Annemieke Floor; Andries S Koster; Henk Buurma
Journal:  Am J Pharm Educ       Date:  2019-08       Impact factor: 2.047

7.  Perspectives of practising pharmacists towards interprofessional education and collaborative practice in Qatar.

Authors:  Alla El-Awaisi; Maguy Saffouh El Hajj; Sundari Joseph; Lesley Diack
Journal:  Int J Clin Pharm       Date:  2018-07-26

8.  Deprescribing in the context of multiple providers: understanding patient preferences.

Authors:  Amy Linsky; Mark Meterko; Barbara G Bokhour; Kelly Stolzmann; Steven R Simon
Journal:  Am J Manag Care       Date:  2019-04       Impact factor: 2.229

9.  Cost analysis for the implementation of a medication review with follow-up service in Spain.

Authors:  Aranzazu Noain; Victoria Garcia-Cardenas; Miguel Angel Gastelurrutia; Amaia Malet-Larrea; Fernando Martinez-Martinez; Daniel Sabater-Hernandez; Shalom I Benrimoj
Journal:  Int J Clin Pharm       Date:  2017-04-22

10.  Service quality and parents' willingness to get adolescents HPV vaccine from pharmacists.

Authors:  Parth D Shah; William A Calo; Macary W Marciniak; Carol E Golin; Betsy L Sleath; Noel T Brewer
Journal:  Prev Med       Date:  2018-01-09       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.